Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Mary has over 20 years of executive experience in the British Columbia health system including her service as the President and CEO of Vancouver Coastal Health (VCH) from 2014-2020 and prior executive positions of Chief Operating Officer and Vice-President Facilities, Real Estate and Process Improvement.

Throughout her career, Mary’s passion has been to transform the public system to ensure sustainability in the face of growing demand and constrained resources. As CEO of VCH, she encouraged a focus on innovation and discoveries to improve patient health, transform health systems, and directly impact health and economic outcomes. Her longstanding interest in virtual care enabled health providers to continue delivering care to patients and clients across VCH from the early days of the COVID-19 pandemic.

In 2019, Glassdoor, one of the world’s largest employee recruitment sites named Mary as one of Canada’s Top 25 CEOs based on employee reviews. She was named as one of Canada’s Most Powerful Women in 2014 and 2015. Over the past year, Mary led the innovation and research agenda at the B.C. Ministry of Health as the Senior Executive in Residence and the lead for the Partnerships and Innovation Division.

Mary is a graduate of the Harvard Business School’s Master’s of Business Administration program and holds a Bachelor’s and Master’s degree in Industrial Engineering from West Virginia University.

Dr. Martin Dawes is a world expert in primary care who combines research and clinical practice with over 30 years of experience. Following the completion of his PhD, he helped develop a Masters program in Evidence Based Health Care. He has directed the UK Centre for Evidence-Based Medicine in Oxford and was the head of family practice at McGill University and the University of British Columbia.

Dr. Kendall Ho’s academic and research interests fall into the domain of technology-enabled knowledge translation (TEKT) – the use of information technologies to accelerate the incorporation of the latest health evidence into routine practice. Specific directions within TEKT include telehealth, information and communication technologies (ICT) and patient safety, ICT and public engagement, and evidence-based policy translation in eHealth.

Drew McArthur retired from TELUS in 2007 as Vice President Corporate Affairs and Chief Compliance Officer. As Chief Compliance Officer, Drew was responsible for legal and regulatory compliance for all of TELUS’ operations, reporting to the Audit Committee of the Board of Directors. The responsibilities of this role included ensuring TELUS had the appropriate controls, policies and measurements in place to be compliant with many areas of law and regulation. Drew played a key role in the privacy community in Canada as a founding member of the Council of Canadian Chief Privacy Officers and a member of the advisory board of the International Association of Privacy Professionals (IAPP). From June 2016 to April 2018, Drew was the Acting Information and Privacy Commissioner for BC, and is now consulting in the area of privacy. He can be contacted at drew.mcarthur@telus.net.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

From 2013 to 2017, John served in the BC Public Service as Deputy Minister of Technology, Innovation and Citizens’ Services. With 1,300 employees and an annual budget of more than $1 billion, the ministry delivered a broad spectrum of government services and economic development programs.

The ministry was responsible for the government’s cyber security strategy and operations, as well as the privacy and freedom of information files. John continues to have a strong interest in the development of privacy and security practice and policy.

Prior to joining the public service, John held a series of senior executive roles in public and private technology companies. Two of his President and CEO roles were with publicly traded companies regulated by both Canadian and United States securities regulators.

Beyond his public service and corporate work, John has long been active in the not-for-profit sector. He was on the Board of the Digital Identity & Authentication Council of Canada (DIACC) from 2013 to 2017 and as a senior board volunteer with a national health charity from 1994 to 2008.

Sarah’s life journey took a change of course upon receiving a challenging diagnosis, then operation for a Meningioma brain tumor in 2017. Her recovery path now is giving back by blending her sales and public speaking background with her health technology experience, to help improve health outcomes for all. She has an unique understanding of what it is like to navigate the health system which provides her with important insights on the needs, preferences and values that are important to users of the system. She is Empowered to be the positive voice of the patient in partnering with healthcare initiatives. Possessing a one-of-a-kind form of expertise on her health condition and how the healthcare system is set up to address it. Through the sharing of her health care journey, her advisor/patient partnership role offers valuable insight on what healthcare does well and where we can make improvements.

She is also a mother to 3 very active and super resilient kids ages 11,14, 15. She considers herself an amazing wife to an exceptional husband for 20 years. As an enthusiastic athlete she is constantly rebuilding  and challenging her neuro pathways.   Her passion about the use of Technology to achieve better health outcomes for all is her strength.

Holly is responsible for guiding the development, recommendation and implementation of innovative approaches to privacy policy and practice to build accountable information stewardship and privacy conscious practices that enable the execution of PHSA’s expanded mandate and the conduct of health research. She advises on the privacy requirements relating to new and expanded provincial initiatives working closely with PHSA’s Information, Access and Privacy, and Legal Services teams. She also provides leadership in developing and implementing governance mechanisms to enable nimble, multidisciplinary review of privacy and security requirements for new and expanded initiatives and research, including province-wide platforms and systems, digital and information technologies, and data access/sharing. Holly is a PhD level trained ethicist and research consultant. She serves as the ethicist on the BC Cancer Research Ethics Board and a US-based IRB. She has worked as a consultant for Health Canada, the Public Health Agency of Canada, and the CIHR Ethics Office and her work has been published in a variety of journals including CMAJ, Trends in Neurosciences and Cell Stem Cell.​

Pieter R. Cullis, Ph.D. FRSC, FNAI (USA), Scientific Director & CEO, NanoMedicines Innovation Network,  Canada’s National Centre of Excellence in nanomedicines; Professor, Department of Biochemistry and  Molecular Biology, University of British Columbia. Dr. Cullis and co-workers have been responsible for fundamental advances in the design and development of nanomedicines employing lipid nanoparticle  (LNP) technology for cancer therapies and gene therapies. This work has contributed to five drugs that have been approved by regulatory agencies in the U.S., Europe and Canada. Dr. Cullis has co-founded  ten biotechnology companies that now employ over 300 people, has published over 350 scientific articles and is an inventor on over 60 patents. He also co-founded the Centre for Drug Research and  Development, a Centre of Excellence for the Commercialization of Research (now AdMare) in 2004, the  Personalized Medicine Initiative (PMI) in 2012 and the NanoMedicines Innovation Network in 2019. Dr.  Cullis was elected a Fellow of the Royal Society of Canada in 2004 and was also awarded the Prix Galien,  Canada’s premier prize for achievements in pharmaceutical R&D, in 2011. Two recently approved drugs that are enabled by LNP delivery systems devised by Dr. Cullis, members of his UBC laboratory and colleagues in the companies he has co-founded deserve special emphasis. The first is Onpattro which was approved by the US FDA in August 2018 to treat the previously fatal hereditary condition transthyretin-induced amyloidosis (hATTR). Onpattro is the first RNAi drug to receive regulatory approval. The second is BNT162b2, the COVID-19 vaccine developed by Pfizer/BioNTech that has now (December 2020) been approved in Canada, the USA, the UK and Europe. It is anticipated that more than 1.3B doses of BNT162b2 will be administered worldwide in 2021.